Profile data is unavailable for this security.
Mergers & acquisitions
| Acquired company | NOVN:SWX since announced | Transaction value |
|---|---|---|
| Avidity Biosciences Inc | 18.27% | 9.99bn |
| Tourmaline Bio Inc | 20.31% | 1.37bn |
| Regulus Therapeutics Inc | 30.67% | 1.62bn |
| Anthos Therapeutics Inc | 26.99% | 3.08bn |
Data delayed at least 15 minutes, as of Feb 11 2026 16:32 GMT.
